$162.10 Nov 18, 2026 · market cap $16.6B
Neurocrine Biosciences trades at $162. Our three models put it at $53–$347 (base $153): between them. The models disagree widely, so read the base with care.
Cash Flow $347 · Buffett $153 · Damodaran $53 · models run Nov 18, 2026
11 of 121 tracked investors hold it · Q3 2026 13F filings
Estimates from SEC filings and market data; the verdict is AI research. Not investment advice. Get the iPhone app · Get the Android app